BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Han C, Romero N, Fischer S, Dookran J, Berger A, Doiron AL. Recent developments in the use of nanoparticles for treatment of biofilms. Nanotechnology Reviews 2017;6:383-404. [DOI: 10.1515/ntrev-2016-0054] [Cited by in Crossref: 32] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Kirtane AR, Verma M, Karandikar P, Furin J, Langer R, Traverso G. Nanotechnology approaches for global infectious diseases. Nat Nanotechnol 2021;16:369-84. [PMID: 33753915 DOI: 10.1038/s41565-021-00866-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
2 Khorsandi K, Keyvani-Ghamsari S, Khatibi Shahidi F, Hosseinzadeh R, Kanwal S. A mechanistic perspective on targeting bacterial drug resistance with nanoparticles. J Drug Target 2021;:1-19. [PMID: 33703979 DOI: 10.1080/1061186X.2021.1895818] [Reference Citation Analysis]
3 Singh A, Verma A, Singh R, Sahoo AK, Samanta SK. Combination therapy of biogenic C-dots and lysozyme for enhanced antibacterial and antibiofilm activity. Nanotechnology 2021;32:085104. [PMID: 33080579 DOI: 10.1088/1361-6528/abc2ed] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
4 Zhuang C, Chen Y. The effect of nano-SiO2 on concrete properties: a review. Nanotechnology Reviews 2019;8:562-72. [DOI: 10.1515/ntrev-2019-0050] [Cited by in Crossref: 31] [Cited by in F6Publishing: 2] [Article Influence: 15.5] [Reference Citation Analysis]
5 Gopalakrishnan V, Masanam E, Ramkumar VS, Baskaraligam V, Selvaraj G. Influence of N-acylhomoserine lactonase silver nanoparticles on the quorum sensing system of Helicobacter pylori: A potential strategy to combat biofilm formation. J Basic Microbiol 2020;60:207-15. [PMID: 31960983 DOI: 10.1002/jobm.201900537] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
6 Ding L, Wang J, Cai S, Smyth H, Cui Z. Pulmonary biofilm-based chronic infections and inhaled treatment strategies. Int J Pharm 2021;604:120768. [PMID: 34089796 DOI: 10.1016/j.ijpharm.2021.120768] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tan M, Reyes-ortega F, Schneider-futschik EK. Magnetic Nanoparticle-Based Drug Delivery Approaches for Preventing and Treating Biofilms in Cystic Fibrosis. Magnetochemistry 2020;6:72. [DOI: 10.3390/magnetochemistry6040072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Kelly SA, Rodgers AM, O’brien SC, Donnelly RF, Gilmore BF. Gut Check Time: Antibiotic Delivery Strategies to Reduce Antimicrobial Resistance. Trends in Biotechnology 2020;38:447-62. [DOI: 10.1016/j.tibtech.2019.10.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
9 Kapustová M, Puškárová A, Bučková M, Granata G, Napoli E, Annušová A, Mesárošová M, Kozics K, Pangallo D, Geraci C. Biofilm inhibition by biocompatible poly(ε-caprolactone) nanocapsules loaded with essential oils and their cyto/genotoxicity to human keratinocyte cell line. Int J Pharm 2021;606:120846. [PMID: 34216769 DOI: 10.1016/j.ijpharm.2021.120846] [Reference Citation Analysis]
10 Dhar Y, Han Y. Current developments in biofilm treatments: Wound and implant infections. Engineered Regeneration 2020;1:64-75. [DOI: 10.1016/j.engreg.2020.07.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
11 Malaekeh-nikouei B, Fazly Bazzaz BS, Mirhadi E, Tajani AS, Khameneh B. The role of nanotechnology in combating biofilm-based antibiotic resistance. Journal of Drug Delivery Science and Technology 2020;60:101880. [DOI: 10.1016/j.jddst.2020.101880] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 9.0] [Reference Citation Analysis]
12 Dian Permana A, Mir M, Utomo E, Donnelly RF. WITHDRAWN: Bacterially sensitive nanoparticle-based dissolving microneedles of doxycycline for enhanced treatment of bacterial biofilm skin infection: A proof of concept study. Int J Pharm 2020;:119220. [PMID: 32165225 DOI: 10.1016/j.ijpharm.2020.119220] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
13 Permana AD, Anjani QK, Sartini, Utomo E, Volpe-zanutto F, Paredes AJ, Evary YM, Mardikasari SA, Pratama MR, Tuany IN, Donnelly RF. Selective delivery of silver nanoparticles for improved treatment of biofilm skin infection using bacteria-responsive microparticles loaded into dissolving microneedles. Materials Science and Engineering: C 2021;120:111786. [DOI: 10.1016/j.msec.2020.111786] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]